- Home
- NRIX vs STC Comparison
NRIX vs STC Comparison
Compare NRIX & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIX | STC |
|---|---|---|
| Founded | 2009 | 1893 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | NRIX | STC |
|---|---|---|
| Price | $14.53 | $65.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $30.50 | ★ $81.00 |
| AVG Volume (30 Days) | ★ 961.1K | 132.4K |
| Earning Date | 04-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.00% |
| EPS Growth | N/A | ★ 55.17 |
| EPS | N/A | ★ 0.55 |
| Revenue | $76,987,000.00 | ★ $2,921,636,000.00 |
| Revenue This Year | N/A | $13.62 |
| Revenue Next Year | $48.05 | $7.13 |
| P/E Ratio | ★ N/A | $115.31 |
| Revenue Growth | ★ 99.31 | 17.32 |
| 52 Week Low | $8.20 | $56.39 |
| 52 Week High | $22.50 | $78.61 |
Technical Indicators
Market Signals| Indicator | NRIX | STC |
|---|---|---|
| Relative Strength Index (RSI) | 32.11 | 47.46 |
| Support Level | $11.67 | $57.11 |
| Resistance Level | $17.06 | $66.06 |
| Average True Range (ATR) | 0.90 | 1.71 |
| MACD | -0.26 | -0.42 |
| Stochastic Oscillator | 3.88 | 47.71 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments: Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.